| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
2,546 |
2,031 |
$2.18M |
| J2778 |
Injection, ranibizumab, 0.1 mg |
1,439 |
991 |
$1.14M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
7,780 |
6,337 |
$473K |
| 92134 |
|
12,837 |
11,737 |
$212K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,088 |
2,953 |
$122K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,983 |
2,282 |
$71K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,620 |
1,555 |
$62K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
910 |
851 |
$25K |
| 92250 |
|
878 |
821 |
$25K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
987 |
934 |
$20K |
| 67228 |
|
122 |
95 |
$19K |
| 92235 |
|
209 |
190 |
$6K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
46 |
39 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
29 |
27 |
$2K |
| 92225 |
|
21 |
12 |
$220.16 |